If you have any question, please feel free to email us. We will touch with you as soon as possible.
CAS:73963-72-1
Source:India
Qualifications:USDMF/-/-/-/-
| Name | Cilostazol |
|---|---|
| Chinese name | 西洛他唑 |
| Cas Number | 73963-72-1 |
| Source | India |
| Qualifications | USDMF/-/-/-/- |
In May 1999, the US FDA approved the drug cilostazol for the treatment of stable intermittent claudication. Prior to this, the drug had been marketed in Japan. The drug can improve ischemic symptoms such as ulcers, limb pain, cold sensation and intermittent claudication caused by chronic arterial occlusive disease. Adjuvant treatment of atherosclerosis, thromboangiitis obliterans, and limb ischemia caused by diabetes. This product is the first drug approved for this indication in the past 15 years. Our company can supply high-quality imported raw materials and support joint declaration.
Hot Tags: cilostazol api, China, suppliers, manufacturers, factory, customized, price, pricelist, in stock, Pleasant API, Deoxycholic Acid API, Lapatinib Ditosylate API, Ticagrelor API, Tippyridine Hydrochloride API, Perindopril Arginine API
Tel:+86-020-61855200-902
Fax:+86-020-66392525
Email:info@upharm.cn
Address:12th floor, No. 181, Kexue Avenue, Huangpu District, Guangzhou, China
